Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:16 PM
Ignite Modification Date:
2025-12-24 @ 4:16 PM
NCT ID:
NCT06246266
Eligibility Criteria:
Inclusion Criteria:
* Born between 38 and 42 weeks of gestation,
* Between 2 and 4 months old,
* Applying to the family health center for KPA (Conjugated Pneumococcal Vaccine) application,
* No congenital anomalies, birth asphyxia or any chronic disease
Exclusion Criteria:
* Born prematurely or postmaturely
* Not between 2 and 4 months old
* Those who come to the family health center for the administration of other vaccines other than the KPA (Conjugated Pneumococcal Vaccine) application administered via IM route.
* Those with congenital anomalies, birth asphyxia or any chronic disease
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
2 Months
Maximum Age:
4 Months
Study:
NCT06246266
Study Brief:
Protocol Section:
NCT06246266